Search

Acquisition Dr. Reddy’s Plans Acquisition of OctoPlus

| Editor: Dominik Stephan

Dr. Reddy’s Laboratories plans to OctoPlus N.V. a service based specialty pharmaceutical company, for OctoPlus N.V. , for an offer price of € 27.39 million. This deal will help expand the expertise and scientific capabilities of Dr. Reddy's.

Related Companies

Pharmaceuticals production at Dr. Reddy. The Indian generics specialists plans the acquisition of OctoPlus
Pharmaceuticals production at Dr. Reddy. The Indian generics specialists plans the acquisition of OctoPlus
(Picture: Dr. Reddy)

Hyderabad/India – G V Prasad, Vice-Chairman and CEO of Dr. Reddy’s said, “As we globalize our R & D efforts, we are looking forward to build a research base in Leiden (Netherlands). The acquisition helps us ramp up our technology capabilities in drug delivery.”

(ID:36451100)